-
公开(公告)号:US20230301873A1
公开(公告)日:2023-09-28
申请号:US18310951
申请日:2023-05-02
申请人: CORNING INCORPORATED
发明人: Joseph Michael Matusick , Sinue Gomez-Mower , Weirong Jiang , Steven Edward DeMar , Christie Leigh McCarthy , Connor Thomas O’Malley , John Stephen Peanasky , Shivani Rao Polasani , James Ernest Webb , Michael Clement Ruotolo , Bryan James Musk , Jared Seaman Aaldenberg , Eric Lewis Allington , Douglas Miles Noni , Amber Leigh Tremper , Kristen Dae Waight , Kevin Patrick McNelis , Patrick Joseph Cimo , Christy Lynn Chapman , Robert Anthony Schaut , Adam Robert Sarafian
CPC分类号: A61J1/1468 , B65D23/0821
摘要: Disclosed herein are glass pharmaceutical vials having sidewalls of reduced thickness. In embodiments, the glass pharmaceutical vial may include a glass body comprising a sidewall enclosing an interior volume. An outer diameter D of the glass body is equal to a diameter d1 of a glass vial of size X as defined by ISO 8362-1, wherein X is one of 2R, 3R, 4R, 6R, 8R, 10R, 15R, 20R, 25R, 30R, 50R, and 100R as defined by ISO 8362-1. However, the sidewall of the glass pharmaceutical vial comprises an average wall thickness Ti that is less than or equal to 0.85*s1, wherein s1 is a wall thickness of the glass vial of size X as defined by ISO 8362-1 and X is one of 2R, 3R, 4R, 6R, 8R, 10R, 15R, 20R, 25R, 30R, 50R, and 100R as defined by ISO 8362-1.
-
公开(公告)号:US20220212985A1
公开(公告)日:2022-07-07
申请号:US17695948
申请日:2022-03-16
申请人: CORNING INCORPORATED
发明人: Matthew John Dejneka , Sinue Gomez-Mower , Guangli Hu , Charlene Marie Smith , Zhongzhi Tang , Steven Alvin Tietje
摘要: Embodiments of a glass-based article including a first surface and a second surface opposing the first surface defining a thickness (t) of about 3 millimeters or less (e.g., about 1 millimeter or less), and a stress profile, wherein all points of the stress profile between a thickness range from about 0·t up to 0.3·t and from greater than about 0.7·t up to t, comprise a tangent with a slope having an absolute value greater than about 0.1 MPa/micrometer, are disclosed. In some embodiments, the glass-based article includes a non-zero metal oxide concentration that varies along at least a portion of the thickness (e.g., 0·t to about 0.3·t) and a maximum central tension in the range from about 80 MPa to about 100 MPa. In some embodiments, the concentration of metal oxide or alkali metal oxide decreases from the first surface to a value at a point between the first surface and the second surface and increases from the value to the second surface. The concentration of the metal oxide may be about 0.05 mol % or greater or about 0.5 mol % or greater throughout the thickness. Methods for forming such glass-based articles are also disclosed.
-
公开(公告)号:US11963928B2
公开(公告)日:2024-04-23
申请号:US18310944
申请日:2023-05-02
申请人: CORNING INCORPORATED
发明人: James Ernest Webb , Sinue Gomez-Mower , Weirong Jiang , Joseph Michael Matusick , Christie Leigh McCarthy , Connor Thomas O'Malley , John Stephen Peanasky , Shivani Rao Polasani , Steven Edward DeMartino , Michael Clement Ruotolo, Jr. , Bryan James Musk , Jared Seaman Aaldenberg , Eric Lewis Allington , Douglas Miles Noni, Jr. , Amber Leigh Tremper , Kristen Dae Waight , Kevin Patrick McNelis , Patrick Joseph Cimo , Christy Lynn Chapman , Robert Anthony Schaut , Adam Robert Sarafian
CPC分类号: A61J1/1468 , B65D23/0821
摘要: Disclosed herein are glass pharmaceutical vials having sidewalls of reduced thickness. In embodiments, the glass pharmaceutical vial may include a glass body comprising a sidewall enclosing an interior volume. An outer diameter D of the glass body is equal to a diameter d1 of a glass vial of size X as defined by ISO 8362-1, wherein X is one of 2R, 3R, 4R, 6R, 8R, 10R, 15R, 20R, 25R, 30R, 50R, and 100R as defined by ISO 8362-1. However, the sidewall of the glass pharmaceutical vial comprises an average wall thickness Ti that is less than or equal to 0.85*s1, wherein s1 is a wall thickness of the glass vial of size X as defined by ISO 8362-1 and X is one of 2R, 3R, 4R, 6R, 8R, 10R, 15R, 20R, 25R, 30R, 50R, and 100R as defined by ISO 8362-1.
-
公开(公告)号:US20230301872A1
公开(公告)日:2023-09-28
申请号:US18310944
申请日:2023-05-02
申请人: CORNING INCORPORATED
发明人: James Ernest Webb , Sinue Gomez-Mower , Weirong Jiang , Joseph Michael Matusick , Christie Leigh McCarthy , Connor Thomas O’Malley , John Stephen Peanasky , Shivani Rao Polasani , Steven Edward DeMartino , Michael Clement Ruotolo, JR. , Bryan James Musk , Jared Seaman Aaldenberg , Eric Lewis Allington , Douglas Miles Noni, JR. , Amber Leigh Tremper , Kristen Dae Waight , Kevin Patrick McNelis , Patrick Joseph Cimo , Christy Lynn Chapman , Robert Anthony Schaut , Adam Robert Sarafian
CPC分类号: A61J1/1468 , B65D23/0821
摘要: Disclosed herein are glass pharmaceutical vials having sidewalls of reduced thickness. In embodiments, the glass pharmaceutical vial may include a glass body comprising a sidewall enclosing an interior volume. An outer diameter D of the glass body is equal to a diameter d1 of a glass vial of size X as defined by ISO 8362-1, wherein X is one of 2R, 3R, 4R, 6R, 8R, 10R, 15R, 20R, 25R, 30R, 50R, and 100R as defined by ISO 8362-1. However, the sidewall of the glass pharmaceutical vial comprises an average wall thickness Ti that is less than or equal to 0.85*s1, wherein s1 is a wall thickness of the glass vial of size X as defined by ISO 8362-1 and X is one of 2R, 3R, 4R, 6R, 8R, 10R, 15R, 20R, 25R, 30R, 50R, and 100R as defined by ISO 8362-1.
-
公开(公告)号:US11963929B2
公开(公告)日:2024-04-23
申请号:US18310964
申请日:2023-05-02
申请人: CORNING INCORPORATED
发明人: Connor Thomas O'Malley , Sinue Gomez-Mower , Weirong Jiang , Joseph Michael Matusick , Christie Leigh McCarthy , Christy Lynn Chapman , John Stephen Peanasky , Shivani Rao Polasani , James Ernest Webb , Michael Clement Ruotolo, Jr. , Bryan James Musk , Jared Seaman Aaldenberg , Eric Lewis Allington , Douglas Miles Noni, Jr. , Amber Leigh Tremper , Kristen Dae Waight , Kevin Patrick McNelis , Patrick Joseph Cimo , Steven Edward DeMartino , Robert Anthony Schaut , Adam Robert Sarafian
CPC分类号: A61J1/1468 , B65D23/0821
摘要: Disclosed herein are glass pharmaceutical vials having sidewalls of reduced thickness. In embodiments, the glass pharmaceutical vial may include a glass body comprising a sidewall enclosing an interior volume. An outer diameter D of the glass body is equal to a diameter d1 of a glass vial of size X as defined by ISO 8362-1, wherein X is one of 2R, 3R, 4R, 6R, 8R, 10R, 15R, 20R, 25R, 30R, 50R, and 100R as defined by ISO 8362-1. However, the sidewall of the glass pharmaceutical vial comprises an average wall thickness Ti that is less than or equal to 0.85*s1, wherein s1 is a wall thickness of the glass vial of size X as defined by ISO 8362-1 and X is one of 2R, 3R, 4R, 6R, 8R, 10R, 15R, 20R, 25R, 30R, 50R, and 100R as defined by ISO 8362-1.
-
公开(公告)号:US20230270627A1
公开(公告)日:2023-08-31
申请号:US18310964
申请日:2023-05-02
申请人: Corning Incorporated
发明人: Connor Thomas O'Malley , Sinue Gomez-Mower , Weirong Jiang , Joseph Michael Matusick , Christie Leigh McCarthy , Christy Lynn Chapman , John Stephen Peanasky , Shivani Rao Polasani , James Ernest Webb , Michael Clement Ruotolo, JR. , Bryan James Musk , Jared Seaman Aaldenberg , Eric Lewis Allington , Douglas Miles Noni, JR. , Amber Leigh Tremper , Kristen Dae Waight , Kevin Patrick McNelis , Patrick Joseph Cimo , Steven Edward DeMartino , Rob Anthony Schaut , Adam Robert Sarafian
CPC分类号: A61J1/1468 , B65D23/0821
摘要: Disclosed herein are glass pharmaceutical vials having sidewalls of reduced thickness. In embodiments, the glass pharmaceutical vial may include a glass body comprising a sidewall enclosing an interior volume. An outer diameter D of the glass body is equal to a diameter d1 of a glass vial of size X as defined by ISO 8362-1, wherein X is one of 2R, 3R, 4R, 6R, 8R, 10R, 15R, 20R, 25R, 30R, 50R, and 100R as defined by ISO 8362-1. However, the sidewall of the glass pharmaceutical vial comprises an average wall thickness Ti that is less than or equal to 0.85*s1, wherein s1 is a wall thickness of the glass vial of size X as defined by ISO 8362-1 and X is one of 2R, 3R, 4R, 6R, 8R, 10R, 15R, 20R, 25R, 30R, 50R, and 100R as defined by ISO 8362-1.
-
公开(公告)号:US20230270626A1
公开(公告)日:2023-08-31
申请号:US18310956
申请日:2023-05-02
申请人: CORNING INCORPORATED
发明人: Christy Lynn Chapman , Sinue Gomez-Mower , Weirong Jiang , Joseph Michael Matusick , Christie Leigh McCarthy , Connor Thomas O'Malley , John Stephen Peanasky , Shivani Rao Polasani , James Ernest Webb , Michael Clement Ruotolo , Bryan James Musk , Jared Seaman Aaldenberg , Eric Lewis Allington , Douglas Miles Noni , Amber Leigh Tremper , Kristen Dae Waight , Kevin Patrick McNelis , Patrick Joseph Cimo , Steven Edward DeMartino , Rob Anthony Schaut , Adam Robert Sarafian
CPC分类号: A61J1/1468 , B65D23/0821
摘要: Disclosed herein are glass pharmaceutical vials having sidewalls of reduced thickness. In embodiments, the glass pharmaceutical vial may include a glass body comprising a sidewall enclosing an interior volume. An outer diameter D of the glass body is equal to a diameter d1 of a glass vial of size X as defined by ISO 8362-1, wherein X is one of 2R, 3R, 4R, 6R, 8R, 10R, 15R, 20R, 25R, 30R, 50R, and 100R as defined by ISO 8362-1. However, the sidewall of the glass pharmaceutical vial comprises an average wall thickness Ti that is less than or equal to 0.85*s1, wherein s1 is a wall thickness of the glass vial of size X as defined by ISO 8362-1 and X is one of 2R, 3R, 4R, 6R, 8R, 10R, 15R, 20R, 25R, 30R, 50R, and 100R as defined by ISO 8362-1.
-
8.
公开(公告)号:US20230233407A1
公开(公告)日:2023-07-27
申请号:US18128681
申请日:2023-03-30
申请人: CORNING INCORPORATED
CPC分类号: A61J1/065 , A61J1/1412 , B65D39/0052 , C03C15/02 , B32B17/06 , B65B7/161 , A61J2200/44 , Y10T428/1352 , Y10T428/13 , Y10T428/1328 , Y10T428/1355 , Y10T428/1397 , Y10T428/131 , Y10T428/1331
摘要: A sealed pharmaceutical container includes a shoulder, a neck extending from the shoulder, and a flange extending from the neck. The flange includes an inclined sealing surface defining an opening in the sealed pharmaceutical container. The sealed pharmaceutical container also includes a sealing assembly including a stopper extending over the sealing surface of the flange and a cap securing the stopper to the flange. The stopper has a glass transition temperature (Tg) that is greater than or equal to −70° C. and less than or equal to −45° C. The sealing assembly maintains a helium leakage rate of the sealed pharmaceutical container of less than or equal to 1.4×10−6 cm3/s as the sealed pharmaceutical container is cooled to a temperature of less than or equal to −45° C.
-
公开(公告)号:US12076297B2
公开(公告)日:2024-09-03
申请号:US18310951
申请日:2023-05-02
申请人: CORNING INCORPORATED
发明人: Joseph Michael Matusick , Sinue Gomez-Mower , Weirong Jiang , Steven Edward DeMartino , Christie Leigh McCarthy , Connor Thomas O'Malley , John Stephen Peanasky , Shivani Rao Polasani , James Ernest Webb , Michael Clement Ruotolo, Jr. , Bryan James Musk , Jared Seaman Aaldenberg , Eric Lewis Allington , Douglas Miles Noni, Jr. , Amber Leigh Tremper , Kristen Dae Waight , Kevin Patrick McNelis , Patrick Joseph Cimo , Christy Lynn Chapman , Robert Anthony Schaut , Adam Robert Sarafian
CPC分类号: A61J1/1468 , B65D23/0821
摘要: Disclosed herein are glass pharmaceutical vials having sidewalls of reduced thickness. In embodiments, the glass pharmaceutical vial may include a glass body comprising a sidewall enclosing an interior volume. An outer diameter D of the glass body is equal to a diameter d1 of a glass vial of size X as defined by ISO 8362-1, wherein X is one of 2R, 3R, 4R, 6R, 8R, 10R, 15R, 20R, 25R, 30R, 50R, and 100R as defined by ISO 8362-1. However, the sidewall of the glass pharmaceutical vial comprises an average wall thickness Ti that is less than or equal to 0.85*s1, wherein s1 is a wall thickness of the glass vial of size X as defined by ISO 8362-1 and X is one of 2R, 3R, 4R, 6R, 8R, 10R, 15R, 20R, 25R, 30R, 50R, and 100R as defined by ISO 8362-1.
-
公开(公告)号:US11865532B2
公开(公告)日:2024-01-09
申请号:US17400161
申请日:2021-08-12
申请人: CORNING INCORPORATED
CPC分类号: B01J49/00 , B01J20/04 , B01J20/28016 , B01J39/09 , B09B3/00
摘要: Embodiments of the present disclosure are directed to methods for recycling waste ion exchange materials comprising a first alkali metal salt and a second alkali metal salt comprising reducing the size of the waste ion exchange materials to produce a plurality of waste ion exchange particles having particle sizes from 0.10 mm to 5.0 mm, and regenerating the plurality of waste ion exchange particles to produce a plurality of regenerated ion exchange particles having a concentration of the first alkali metal salt greater than a concentration of the first alkali metal salt in the waste ion exchange materials. Systems for recycling a waste ion exchange materials comprising a first alkali metal salt and a second alkali metal salt are also disclosed.
-
-
-
-
-
-
-
-
-